Vyxeos for Induction of Low- or Intermediate-risk.
Vyxeos for Induction of Low- or Intermediate-risk.
Active, not recruiting · NCT05599360 · Registry updated 2026-10-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Vyxeos for Induction of Low- or Intermediate-risk. | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Active, not recruiting | Phase 2 | 2026-10-08 | NCT05599360 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shaare Zedek Medical Center | 21 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Shaare Zedek Medical Center | Jerusalem | Israel | 13 |